(Reuters) - Activist investor Glenview Capital Management, which has been trying to raise its stake in hospital operator Health Management Associates Inc, said it is nominating eight candidates to replace the company's current board. The company has nine members on its board, according to its website. Glenview has been pushing the company since mid-June to remove or amend its poison pill clause so that it can increase its stake to 25 percent from the current 14.6 percent. HMA adopted the clause in May after Glenview indicated that it would raise its stake.
